Please report any queries concerning the funding data grouped in the sections named "Externally Awarded" or "Internally Disbursed" (shown on the profile page) to
your Research Finance Administrator. Your can find your Research Finance Administrator at http://www.ucl.ac.uk/finance/research/post_award/post_award_contacts.php by entering your department
Please report any queries concerning the student data shown on the profile page to:
Email: portico-services@ucl.ac.uk
Help Desk: http://www.ucl.ac.uk/ras/portico/helpdesk
Email: portico-services@ucl.ac.uk
Help Desk: http://www.ucl.ac.uk/ras/portico/helpdesk
› More search options
Mr Mark Feneley
Tel: 08451555000
Appointment
- Honorary Senior Lecturer
- Department of Tissue & Energy
- Div of Surgery & Interventional Sci
- Faculty of Medical Sciences
Biography
My clinical practice has utilized laser treatment for BPH since 2006, including Greenlight Photoselective Vaporisation of Prostate (PVP) and Thulium Vaporesection and Enucleation. My oncological practice in bladder cancer includes photodynamic diagnosis of bladder cancer, intravesical therapies for bladder cancer including their evaluation in clinical trials (chemotherapy, immunotherapy, electromotive drug administration with chemotherapy, hyperthermia with chemotherapy).
Research Groups
See More
See LessResearch Themes
See More See LessResearch Summary
Principle Investigator, UCLH: HYMN - A randomised controlled, phase III trial comparing hyperthermia plus mitomycin to a second course of bacillus Calmette-Guérin or standard therapy in patients with recurrence of non-muscle invasive bladder cancer following induction or maintenance bacillus Calmette-Guérin therapy. This includes investigation of electromotive Mitomycin.
Lead for multicentre development of Patient-reported Outcomes Measures for bladder cancer. Trial Co-Investigator for: Evaluation of Urinary Biomarkers for the Detection of Bladder Cancer
Boxit: A randomised phase III placebo-controlled trial evaluating the addition of celecoxib to standard treatment of transitional cell carcinoma of the bladder.
Proposal as Lead Investigator for investigation of laser for treatment of benign prostatic hyperplasia, in a prospective, randomised multicentre trial.
Teaching Summary
Training Courses in Prostate Laser Surgery
International Training Courses in Androgen Deficiency
Teaching and Examining for UCL and Royal Free Medical School
Contributions to symposia on history of urology
Presentations at International Meetings
Authorship (peer reviewed articles, journal supplements, book chapters and whole textbooks)
Appointments
| 01-SEP-2010 | Honorary Consultant Urologist | Department of Urology | Whittington Hospital NHS Trust, United Kingdom |
| 01-AUG-2010 | Consultant Urologist | Department of Urology | UCLH NHS Foundation Trust, United Kingdom |
| 01-AUG-2010 | Honorary Senior Lecturer | Division of Surgery & Interventional Sciences | University College London, United Kingdom |
Academic Background
| 1991 | FRCS | Fellow Of The Royal College Of Surgeons – Surgery |
